155 related articles for article (PubMed ID: 35146119)
1. Contrast Induced Nephropathy: Efficacy of matched hydration and forced diuresis for prevention in patients with impaired renal function undergoing coronary procedures-CINEMA trial.
Mirza AJ; Ali K; Huwez F; Taha AY; Ahmed FJ; Ezzaddin SA; Abdulrahman ZI; Lang CC
Int J Cardiol Heart Vasc; 2022 Apr; 39():100959. PubMed ID: 35146119
[TBL] [Abstract][Full Text] [Related]
2. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
[TBL] [Abstract][Full Text] [Related]
3. High-volume forced diuresis with matched hydration using the RenalGuard System to prevent contrast-induced nephropathy: A meta-analysis of randomized trials.
Shah R; Wood SJ; Khan SA; Chaudhry A; Rehan Khan M; Morsy MS
Clin Cardiol; 2017 Dec; 40(12):1242-1246. PubMed ID: 29247527
[TBL] [Abstract][Full Text] [Related]
4. Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: study protocol for a randomised controlled trial.
Bolt LJJ; Sigterman TA; Krasznai AG; Sikkink CJM; Schurink GH; Bouwman LH
BMJ Open; 2018 Oct; 8(9):e021842. PubMed ID: 30287607
[TBL] [Abstract][Full Text] [Related]
5. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
[TBL] [Abstract][Full Text] [Related]
6. Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI.
Mauler-Wittwer S; Sievert H; Ioppolo AM; Mahfoud F; Carrié D; Lipiecki J; Nickenig G; Fajadet J; Eckert S; Morice MC; Garot P
JACC Cardiovasc Interv; 2022 Aug; 15(16):1639-1648. PubMed ID: 35981838
[TBL] [Abstract][Full Text] [Related]
7. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.
Liu Y; Chen JY; Huo Y; Ge JB; Xian Y; Duan CY; Chen SQ; Jiang W; Chen PY; Tan N;
Am Heart J; 2016 Feb; 172():88-95. PubMed ID: 26856220
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Stevens MA; McCullough PA; Tobin KJ; Speck JP; Westveer DC; Guido-Allen DA; Timmis GC; O'Neill WW
J Am Coll Cardiol; 1999 Feb; 33(2):403-11. PubMed ID: 9973020
[TBL] [Abstract][Full Text] [Related]
9. Prevention of contrast-induced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure.
Qian G; Liu CF; Guo J; Dong W; Wang J; Chen Y
Clin Cardiol; 2019 Jan; 42(1):21-25. PubMed ID: 30054906
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
Qian G; Fu Z; Guo J; Cao F; Chen Y
JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
[TBL] [Abstract][Full Text] [Related]
11. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
12. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
Barbanti M; Gulino S; Capranzano P; Immè S; Sgroi C; Tamburino C; Ohno Y; Attizzani GF; Patanè M; Sicuso R; Pilato G; Di Landro A; Todaro D; Di Simone E; Picci A; Giannetto G; Costa G; Deste W; Giannazzo D; Grasso C; Capodanno D; Tamburino C
JACC Cardiovasc Interv; 2015 Oct; 8(12):1595-604. PubMed ID: 26386766
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of Hydration with Normal Saline Versus Hydration with Sodium Bicarbonate in the Prevention of Contrast-induced Nephropathy.
Mahmoodi K; Sohrabi B; Ilkhchooyi F; Malaki M; Khaniani ME; Hemmati M
Heart Views; 2014 Apr; 15(2):33-6. PubMed ID: 25104980
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
15. Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography.
Calabrò P; Bianchi R; Crisci M; Caprile M; Bigazzi MC; Palmieri R; Golia E; De Vita A; Romano IJ; Limongelli G; Russo MG; Calabrò R
Intern Emerg Med; 2011 Dec; 6(6):503-7. PubMed ID: 21279477
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
17. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
Koc F; Ozdemir K; Kaya MG; Dogdu O; Vatankulu MA; Ayhan S; Erkorkmaz U; Sonmez O; Aygul MU; Kalay N; Kayrak M; Karabag T; Alihanoglu Y; Gunebakmaz O
Int J Cardiol; 2012 Mar; 155(3):418-23. PubMed ID: 21106264
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.
Dorval JF; Dixon SR; Zelman RB; Davidson CJ; Rudko R; Resnic FS
Int J Cardiol; 2013 Jun; 166(2):482-6. PubMed ID: 22204847
[TBL] [Abstract][Full Text] [Related]
19. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
20. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.
Ibrahim TA; El-Mawardy RH; El-Serafy AS; El-Fekky EM
Cardiovasc Revasc Med; 2017; 18(5):315-319. PubMed ID: 28532702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
